Pharmaceuticals, Biotechnology and Life Sciences
VANCOUVER, British Columbia–(BUSINESS WIRE)–#antibodies—AbCellera, a leader in therapeutic antibody discovery from natural immune systems, has appointed Dr. Michael Hayden to…
Advances in diagnosis will drive market growth in North America LONDON–(BUSINESS WIRE)–#Healthcare–Technavio’s report on the cervical cancer therapeutics market is…
Collaboration Gives Beam Exclusive License for Use of Novel Emerging Gene Editing Technology to Treat Sickle Cell Disease and for…
LACHEN, Switzerland–(BUSINESS WIRE)–Octapharma has announced the publication of new data demonstrating that the fibrinogen concentrate fibryga® is an effective alternative…
Animal model for the study of Chronic Myocardial Infarction indicates, for the first time, regenerative potential in a pig’s heart…
EMERYVILLE, Calif.–(BUSINESS WIRE)–Eureka Therapeutics, Inc., a clinical stage biotechnology company developing novel T-cell therapies to treat cancers, today announced a…
PALO ALTO, Calif.–(BUSINESS WIRE)–Medable Inc., a leading provider of a digital trial platform connecting patients, sites, and clinical trial teams,…
15 patients have been randomized 83% initial response rate to qualify for randomization Pulmonary capillary wedge pressure (PCWP) was reduced…
SAN DIEGO–(BUSINESS WIRE)–Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today…
First-in-human phase 1/2 study evaluating DS-7300, a B7-H3 targeting ADC, in patients with advanced/unresectable or metastatic solid tumors B7-H3 is…